结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展

doi:10.3760/cma.j.cn441417-20240905-04007

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (6): 914-917.DOI: 10.3760/cma.j.cn441417-20240905-04007

结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展

潘文昕¹ 姜伟炜²

¹滨州医学院第二临床医学院，烟台 264100；²滨州医学院烟台附属医院消化内科，烟台 264100

收稿日期:2024-09-05 出版日期:2025-03-15 发布日期:2025-03-17
通讯作者: 姜伟炜，Email：122743098@qq.com
基金资助:
山东省医药卫生科技项目（202303031100）

Advances in research on impact of colonoscopy timing on prognosis of patients with ischemic colitis

Pan Wenxin¹, Jiang Weiwei²

¹Second Clinical Medical College, Binzhou Medical University, Yantai 264100, China; ²Department of Gastroenterology, The Affiliated Yantai Hospital of Binzhou Medical University, Yantai 264100, China
Corresponding author: Jiang Weiwei, Email: 122743098@qq.com

Received:2024-09-05 Online:2025-03-15 Published:2025-03-17
Contact: Jiang Weiwei, Email: 122743098@qq.com
Supported by:
Project of Medical and Health Science and Technology in Shandong Province (202303031100)

摘要/Abstract

摘要：

缺血性结肠炎（ischemic colitis，IC）是一种胃肠道缺血的表现形式，以腹痛、腹泻、便血为主要临床症状，其表现与炎症性肠病相似，且在老年人群中发病率较高，诊断金标准为结肠镜检查。IC的治疗根据个体缺血程度的不同而有较大的差异。因为IC的临床症状及在全腹CT等检查中的表现与炎症性肠病、感染性肠炎等相似，所以如果不能及时诊断IC，易出现治疗方向错误。这不仅会延误病情，导致病情进一步加重，还会增加患者经济负担及心理压力。因此，在避免相关风险的情况下及时完善结肠镜检查以确诊IC是必要的，也是改善患者预后的重要手段。

关键词:

缺血性结肠炎, 结肠镜检查, 炎症性肠病, 预后, 进展

Abstract:

Ischemic colitis (IC) is a manifestation of gastrointestinal ischemia, and is primarily characterized by abdominal pain, diarrhea, and hematochezia. Its clinical presentation is similar to that of inflammatory bowel diseases, and the incidence rate is higher in the elderly population. The gold standard for diagnosing IC is colonoscopy. Treatment varies depending on the severity of ischemia. The clinical symptoms of IC, as well as its manifestations in imaging studies such as abdominal CT, resemble those of inflammatory bowel disease, infectious colitis, and other conditions. Therefore, failure to promptly diagnose IC can lead to incorrect treatment strategies, which may not only delay the appropriate management, potentially exacerbating the conditions, but also increase the patients' economic burden and psychological stress. Therefore, timely colonoscopy, when it is safe to do so, is crucial for diagnosing IC and improving the patients' outcomes.

Key words:

Ischemic colitis, Colonoscopy, Inflammatory bowel diseases, Prognosis, Progress

潘文昕姜伟炜.

结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 914-917.

Pan Wenxin, Jiang Weiwei.

Advances in research on impact of colonoscopy timing on prognosis of patients with ischemic colitis [J]. International Medicine and Health Guidance News, 2025, 31(6): 914-917.

参考文献

[1] Yngvadottir Y, Karlsdottir BR, Hreinsson JP, et al. The incidence and outcome of ischemic colitis in a population-based setting [J]. Scand J Gastroenterol, 2017, 52(6-7): 704-710. DOI: 10.1080/00365521.2017. 1291718.
[2] Khanal S, Bhatt T, Schmidt P, et al. Ischemic colitis or colon cancer: a diagnostic dilemma [J]. Cureus, 2023, 15(3):e36206. DOI: 10.7759/cureus.36206.
[3] Ahmed M. Ischemic bowel disease in 2021 [J]. World J Gastroenterol, 2021, 27(29): 4746-4762. DOI: 10.3748/wjg.v27.i29.4746.
[4] Ahmed M. Ischemic bowel disease in 2021 [J]. World J Gastroenterol, 2021, 27(29): 4746-4762. DOI: 10.3748/wjg.v27.i29.4746.
[5] Shi J, Chen G, Zhang M. Unexpected form of ischemic colitis: a case report [J]. Exp Ther Med, 2023, 26(3): 419. DOI: 10.3892/etm.2023.12118.
[6] 徐慧鲜,刘振锋. 缺血性结肠炎患者结肠镜下表现及缺血修饰白蛋白的诊断价值分析[J]. 中国内镜杂志, 2023, 29(6): 38-43. DOI:10.12235/E20220214.
[7] 吴树荣,张志伟,苏尚平,等.结肠镜联合D-二聚体检测及腹部CT在缺血性结肠炎诊断中的应用价值[J]. 中国实用医刊, 2022, 49(15): 81-84. DOI: 10.3760/cma.j.cn115689- 20220509-02041.
[8] Xu Y, Xiong L, Li Y, et al. Diagnostic methods and drug therapies in patients with ischemic colitis [J]. Int J Colorectal Dis, 2021, 36(1): 47-56. DOI: 10.1007/s00384- 020-03739-z.
[9] 王洁,黄杰安. 缺血性结肠炎早期诊治的研究进展[J]. 临床内科杂志,2019,36(7):440-443. DOI:10.3969/j.issn. 1001-9057.2019.007.003.
[10] Huang H, Wang H, Long Z, et al. Factors influencing hospital stay duration for patients with mild ischemic colitis: a retrospective study [J]. Eur J Med Res, 2022, 27(1): 36. DOI: 10.1186/s40001-022-00665-4.
[11] 胡崇晖,宋泽军,于庚平,等. 缺血性结肠炎的危险因素识别研究进展[J]. 胃肠病学和肝病学杂志,2023,32(6):690-692. DOI:10.3969/j.issn.1006-5709.2023.06.018.
[12] Tin S, Lim W, Umyarova R, et al. Unusual case of ischemic colitis caused by low-dose sumatriptan therapy in a generally healthy patient after strenuous physical activity [J]. Cureus, 2021, 13(8): e17125. DOI: 10.7759/cureus. 17125.
[13] Sadalla S, Lisotti A, Fuccio L, et al. Colonoscopy-related colonic ischemia [J]. World J Gastroenterol, 2021, 27(42): 7299-7310. DOI: 10.3748/wjg.v27.i42.7299.
[14] Qiu H, Li WP. Contrast-induced ischemic colitis following coronary angiography: a case report [J]. World J Clin Cases, 2023, 11(20): 4937-4943. DOI: 10.12998/wjcc.v11.i20.4937.
[15] 田舒杨,金海燕. 缺血性结肠炎的诊断与治疗研究进展[J]. 延边大学医学学报, 2022, 45(2): 132-135. DOI:10.16068/j.1000-1824.2022.02.014.
[16] Doulberis M, Panagopoulos P, Scherz S, et al. Update on ischemic colitis: from etiopathology to treatment including patients of intensive care unit [J]. Scand J Gastroenterol, 2016, 51(8): 893-902. DOI: 10.3109/00365521.2016.1162325.
[17] Wu X, Bao Z. Population-based study of the clinical characteristics and risk factors of ischemic colitis [J]. Turk J Gastroenterol, 2021, 32(4): 393-400. DOI: 10.5152/tjg.2021.20588.
[18] 李玥, 俎明, 丁士刚. 药物相关缺血性结肠炎的研究进展[J]. 胃肠病学和肝病学杂志, 2022, 31(1): 5-8. DOI:10.3969/j.issn.1006-5709.2022.01.002.
[19] 陈柯豫,黄艳齐,张玲利. 缺血性肠炎的临床表现及内镜特点分析[J]. 中国现代医生, 2023, 61(19): 1-3, 23. DOI: 10.3969/j.issn.1673-9701.2023.19.001.
[20] Bala M, Catena F, Kashuk J, et al. Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery [J]. World J Emerg Surg, 2022, 17(1): 54. DOI: 10.1186/s13017-022-00443-x.
[21] 庄柳情,王雷,吴劲松. 缺血性结肠炎的CT和和CTA诊断及分期价值[J]. 现代医用影像学,2017,26(3):653-655.
[22] Feuerstadt P, Brandt LJ. Colon ischemia: recent insights and advances [J]. Curr Gastroenterol Rep, 2010, 12(5): 383-390. DOI: 10.1007/s11894-010-0127-y.
[23] Pigò F, Reggiani Bonetti L, Conigliaro R. Endoscopic features of non-IBD colitis [J]. Asian J Med Sci, 2023, 14(12): 183-191. DOI:10.3126/ajms.v14i12.56578.
[24] Lorenzo D, Barthet M, Serrero M, et al. Severe acute ischemic colitis: What is the place of endoscopy in the management strategy? [J]. Endosc Int Open, 2021, 9(11): E1770-E1777. DOI: 10.1055/a-1561-2259.
[25] 龙禛朴,余阳华,陈霄霄,等.缺血性结肠炎临床特征分析:附101报告[J].中国普通外科杂志,2020,29(8):979-986.
[26] Sonia P, Adeel S, Kathryn S, et al. 727. Outcomes of antibiotic use in ischemic colitis [J]. Open Forum Infect Dis, 2020, 7(Suppl 1): S413-S414. DOI: 10.1093/OFID/OFAA439.919.
[27] Mosli M, Aldabbagh A, Aseeri H, et al. The diagnostic yield of urgent colonoscopy in acute lower gastrointestinal bleeding [J]. Acta Gastroenterol Belg, 2020, 83(2):265-270.
[28] Gilshtein H, Hallon K, Kluger Y. Ischemic colitis caused increased early and delayed mortality [J]. World J Emerg Surg, 2018, 13: 31. DOI: 10.1186/s13017-018-0193-2.
[29] Versaci A, Macrì A, Scuderi G, et al. Ischemic colitis following colonoscopy in a systemic lupus erythematosus patient: report of a case [J]. Dis Colon Rectum, 2005, 48(4): 866-869. DOI: 10.1007/s10350-004-0837-z. PMID: 15750796.
[30] Mahajan A, Musunuri B, Shetty S. Colonoscopy induced ischemic colitis: An endoscopic and histological assay [J]. Clin Res Hepatol Gastroenterol, 2022, 46(8): 101975. DOI: 10.1016/j.clinre.2022.101975.

结肠镜检查时机对缺血性结肠炎患者预后影响的研究进展

Advances in research on impact of colonoscopy timing on prognosis of patients with ischemic colitis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	李勇平吴水淼焦亲任佳辉张潇. 血清Syndecan-1、Endocan-1、GRP78与老年重症肺炎并发ARDS患者病情及预后的关系 [J]. 国际医药卫生导报, 2025, 31(7): 1173-1178.
[2]	张进萍陈玲黄震宇王颖黄晓玲黄豪博. 初治弥漫大B细胞淋巴瘤患者血清白细胞介素-6水平及其预后意义 [J]. 国际医药卫生导报, 2025, 31(7): 1179-1183.
[3]	朱鹏唐文玲覃刚. 结直肠癌中微小RNA功能及临床价值进展 [J]. 国际医药卫生导报, 2025, 31(6): 886-890.
[4]	于明英李媛燕普. 3D和2D腹腔镜手术治疗胃肠道癌症患者的短期预后比较 [J]. 国际医药卫生导报, 2025, 31(6): 900-907.
[5]	张子怡孙大康. TRIM22抗HIV-1作用机制研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 918-922.
[6]	易伟米倩倩赵洁李博宇王丹. 彩色多普勒血流成像在球后血流动力学检测中的应用 [J]. 国际医药卫生导报, 2025, 31(6): 922-926.
[7]	陈秀珠张凯韦岩笑丛晨阳. 甲状腺相关眼病的药物治疗研究进展 [J]. 国际医药卫生导报, 2025, 31(6): 927-929.
[8]	郭玉格刘维帅马平丽. 子宫内膜癌组织中增殖基因表达情况与患者病理及预后的关系 [J]. 国际医药卫生导报, 2025, 31(6): 954-959.
[9]	张雪锋吕艳艳戴璐. 血清JAK-STAT信号通路相关蛋白对类风湿性关节炎患者的预后评估 [J]. 国际医药卫生导报, 2025, 31(6): 960-964.
[10]	文斐岑瑞祥. 3-磷酸甘油醛脱氢酶在喉部鳞状细胞癌中的功能及临床意义 [J]. 国际医药卫生导报, 2025, 31(6): 965-972.
[11]	谢紫阳姜小建孙佳折彦儒. 原发性肺癌患者血清非编码长链RNA及微RNA表达水平与预后的关系 [J]. 国际医药卫生导报, 2025, 31(6): 983-989.
[12]	李晓童于胜强. 肾小管细胞来源外泌体在肾纤维化中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 712-718.
[13]	张涵孙婷王延飞张肖林车娟. 移植后淋巴组织增生性疾病在儿童扁桃体腺样体肥大中的研究进展 [J]. 国际医药卫生导报, 2025, 31(5): 752-757.
[14]	莫家婵范万峰姜兴岳. 基于磁共振成像的影像组学在垂体腺瘤中的应用现状及进展 [J]. 国际医药卫生导报, 2025, 31(5): 757-760.
[15]	赵金鹏高呈飞吕晓东. 浸润性非小细胞肺癌患者水平裂分化情况及肿瘤边缘-水平裂距离与预后的关系 [J]. 国际医药卫生导报, 2025, 31(5): 761-765.